Amrutanjan Health Care Ltd (AMRUTANJAN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bliss GVS Pharma

Shukra Pharma.

Amrutanjan Healt

Syncom Formul.

Windlas Biotech

Indoco Remedies

Novartis India

Morepen Labs.

Solara Active

Panacea Biotec

Beta Drugs Ltd

Why is Amrutanjan Health Care Ltd ?

High Management Efficiency with a high ROE of 18.42%

Company has a low Debt to Equity ratio (avg) at 0 times

Poor long term growth as Net Sales has grown by an annual rate of 10.85% and Operating profit at 2.59% over the last 5 years

Positive results in Sep 25

OPERATING CF(Y) Highest at Rs 50.90 Cr
PAT(9M) At Rs 37.45 cr has Grown at 24.50%
ROCE(HY) Highest at 22.54%

With ROE of 16.6, it has a Attractive valuation with a 5.6 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -10.64%, its profits have risen by 19.3% ; the PEG ratio of the company is 1.7

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -1.34% over the previous quarter and collectively hold 15.29% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -10.64% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Amrutanjan Healt should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Amrutanjan Healt for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Amrutanjan Healt

-11.04%

-0.41

27.24%

Sensex

4.83%

0.41

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.85%

EBIT Growth (5y)

2.59%

EBIT to Interest (avg)

54.24

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

1.45

Tax Ratio

26.70%

Dividend Payout Ratio

26.16%

Pledged Shares

Institutional Holding

15.29%

ROCE (avg)

33.76%

ROE (avg)

18.42%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.58

EV to EBIT

30.96

EV to EBITDA

27.97

EV to Capital Employed

6.57

EV to Sales

3.93

PEG Ratio

1.74

Dividend Yield

0.70%

ROCE (Latest)

21.24%

ROE (Latest)

16.58%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

OPERATING CF(Y)

Highest at Rs 50.90 Cr

PAT(9M)

At Rs 37.45 cr has Grown at 24.50%

ROCE(HY)

Highest at 22.54%

DPS(Y)

Highest at Rs 4.60

PBT LESS OI(Q)

At Rs 14.91 cr has Grown at 25.40%

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Amrutanjan Healt

Operating Cash Flow - Annually

Highest at Rs 50.90 Cr and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Profit After Tax (PAT) - Latest six months

At Rs 22.27 cr has Grown at 35.63%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 14.91 cr has Grown at 25.40%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Dividend per Share (DPS) - Annually

Highest at Rs 4.60

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (Rs)